Skip to main content
. 2017 Jan-Mar;15(1):85–91. doi: 10.1590/S1679-45082017GS3792

Table 2. Active ingredients of the medications most frequently required through lawsuits in the Federal Court.

Medications n (%)
Tiotropium bromide 24 (6.3)
Palivizumab 24 (6.3)
Teriparatide 15 (3.9)
Rituximab 15 (3.9)
Ranibizumab 14 (3.6)
Denosumab 14 (3.6)
Abiraterone acetate 14 (3.6)
Insulins 13 (3.4)
Mycophenolate mofetil 11 (2.9)
Cinacalcet 11 (2.9)
Cetuximab 10 (2.6)
Transtuzumab 10 (2.6)
Ustekinumab 10 (2.6)
Others 199 (51.8)